BiosimilarBrand-NameDrugAdherenceFDAApprovalPharmacyBenefitManager(PBM)HealthEconomicsand OutcomesResearch(HEOR)PipelineDrugHealthPlanClinicalTrialTieredFormularySpecialtyDrugP&TCommitteeMail-OrderPharmacyStepTherapyRebateNon-PreferredDrugPriorAuthorizationCopayOut-of-PocketCostPreferredDrugCostSharingIndicationClaimsDataUtilizationManagementPharmacyBenefitValue-BasedCareGenericDrugFormularyNetworkPharmacyReal-WorldEvidenceMedicalBenefitMarketAccessBiosimilarBrand-NameDrugAdherenceFDAApprovalPharmacyBenefitManager(PBM)HealthEconomicsand OutcomesResearch(HEOR)PipelineDrugHealthPlanClinicalTrialTieredFormularySpecialtyDrugP&TCommitteeMail-OrderPharmacyStepTherapyRebateNon-PreferredDrugPriorAuthorizationCopayOut-of-PocketCostPreferredDrugCostSharingIndicationClaimsDataUtilizationManagementPharmacyBenefitValue-BasedCareGenericDrugFormularyNetworkPharmacyReal-WorldEvidenceMedicalBenefitMarketAccess

GBM 1: Managed Care Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
  1. Biosimilar
  2. Brand-Name Drug
  3. Adherence
  4. FDA Approval
  5. Pharmacy Benefit Manager (PBM)
  6. Health Economics and Outcomes Research (HEOR)
  7. Pipeline Drug
  8. Health Plan
  9. Clinical Trial
  10. Tiered Formulary
  11. Specialty Drug
  12. P&T Committee
  13. Mail-Order Pharmacy
  14. Step Therapy
  15. Rebate
  16. Non-Preferred Drug
  17. Prior Authorization
  18. Copay
  19. Out-of-Pocket Cost
  20. Preferred Drug
  21. Cost Sharing
  22. Indication
  23. Claims Data
  24. Utilization Management
  25. Pharmacy Benefit
  26. Value-Based Care
  27. Generic Drug
  28. Formulary
  29. Network Pharmacy
  30. Real-World Evidence
  31. Medical Benefit
  32. Market Access